P17.38 Plasma drug levels of nevirapine predict virological response in patients receiving treatment in kenyan hospitals
Maureen J. Kimulwo(Strathmore University), Washingtone Ochieng(Strathmore University), RM Lwembe(Kenya Medical Research Institute), M Muigai(Jomo Kenyatta University of Agriculture and Technology), Bernhards Ogutu, Geoffrey Masankwa(Strathmore University), Javan Okendo(National Human Genome Research Institute), RC Kitawi(Strathmore University), RS Mwatelah(Strathmore University), Rashid Aman(King Abdullah University of Science and Technology)
Cited by 0
Related Papers
RNA virus interference via CRISPR/Cas13a system in plants
|Genome biology|2018|1.5k
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies
|ACS Synthetic Biology|2020|407
iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2
|Virus Research|2020|315